We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$275M
AUM Growth
-$37.7M
Cap. Flow
-$45.2M
Cap. Flow %
-16.45%
Top 10 Hldgs %
42.79%
Holding
55
New
2
Increased
8
Reduced
41
Closed
1

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.02M
2
PAYX icon
Paychex
PAYX
+$1.97M
3
CVX icon
Chevron
CVX
+$1.79M
4
GE icon
GE Aerospace
GE
+$1.78M
5
NVS icon
Novartis
NVS
+$1.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.65%
2 Technology 14.14%
3 Energy 13.37%
4 Healthcare 12.97%
5 Financials 11.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
26
Verizon
VZ
$195B
$3.6M 1.31%
64,495
-13,180
-17% -$684K
USB icon
27
US Bancorp
USB
$98.1B
$3.5M 1.27%
86,671
-29,010
-25% -$1.21M
PKG icon
28
Packaging Corp of America
PKG
$21.9B
$3.46M 1.26%
51,665
-12,833
-20% -$838K
PNC icon
29
PNC Financial Services
PNC
$99.7B
$3.32M 1.21%
40,745
-13,931
-25% -$1.2M
LYB icon
30
LyondellBasell Industries
LYB
$20.1B
$3.19M 1.16%
42,851
-10,163
-19% -$839K
HUBB icon
31
Hubbell
HUBB
$24.9B
$2.61M 0.95%
24,746
-1,761
-7% -$185K
RTN
32
DELISTED
Raytheon Company
RTN
$2.29M 0.83%
16,860
+1,694
+11% +$221K
HON icon
33
Honeywell
HON
$77.6B
$2.24M 0.82%
21,415
-4,732
-18% -$486K
ACN icon
34
Accenture
ACN
$101B
$2.08M 0.76%
18,402
-6,758
-27% -$784K
AMGN icon
35
Amgen
AMGN
$208B
$1.72M 0.63%
11,324
-4,578
-29% -$712K
NVO
36
Novo Nordisk
NVO
$206B
$1.68M 0.61%
62,582
-35,698
-36% -$979K
CVS icon
37
CVS Health
CVS
$134B
$1.63M 0.59%
16,971
-7,173
-30% -$715K
SBUX icon
38
Starbucks
SBUX
$121B
$1.53M 0.56%
26,772
-19,035
-42% -$1.08M
SYK icon
39
Stryker
SYK
$125B
$1.05M 0.38%
8,777
-4,570
-34% -$511K
XOM icon
40
ExxonMobil
XOM
$640B
$950K 0.35%
10,138
SRE icon
41
Sempra
SRE
$58.4B
$916K 0.33%
16,076
-6,400
-28% -$339K
UNP icon
42
Union Pacific
UNP
$173B
$843K 0.31%
9,662
-3,412
-26% -$289K
CAH icon
43
Cardinal Health
CAH
$53.9B
$728K 0.27%
9,338
-4,479
-32% -$357K
AGG icon
44
iShares Core US Aggregate Bond ETF
AGG
$137B
$596K 0.22%
5,289
+101
+2% +$11.2K
IVV icon
45
iShares Core S&P 500 ETF
IVV
$877B
$589K 0.21%
2,799
+64
+2% +$13.4K
EFA icon
46
iShares MSCI EAFE ETF
EFA
$78.1B
$556K 0.2%
9,955
+49
+0.5% +$2.82K
IJH icon
47
iShares Core S&P Mid-Cap ETF
IJH
$122B
$465K 0.17%
15,580
+5
+0% +$147
IJR icon
48
iShares Core S&P Small-Cap ETF
IJR
$110B
$443K 0.16%
7,626
+68
+0.9% +$3.88K
IWF icon
49
iShares Russell 1000 Growth ETF
IWF
$121B
$414K 0.15%
16,484
+824
+5% +$20.6K
PH icon
50
Parker-Hannifin
PH
$123B
$280K 0.1%
2,588

Similar funds

Brookmont Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Brookmont Capital Management held 55 positions worth $275M, down 12% from $312M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Brookmont Capital Management withdrew a net $45.2M in Q2 2016, closing 1 position and reducing 41 holdings. Its most notable exit was Qualcomm, an estimated $936K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Energy.

Against the trend, Brookmont Capital Management opened a new position in Vanguard Intermediate-Term Bond ETF worth $205K.

  • Brookmont Capital Management's largest Q2 2016 buy was Vanguard Intermediate-Term Bond ETF: 2,325 shares worth $205K.
  • Brookmont Capital Management added most to Raytheon Company in Q2 2016, an estimated $221K increase.
  • Brookmont Capital Management's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $2.02M.
  • Brookmont Capital Management fully exited Qualcomm in Q2 2016, selling an estimated $936K.
  • Brookmont Capital Management's ten largest holdings make up 43% of its $275M portfolio in Q2 2016.
  • Brookmont Capital Management opened 2 new positions and closed 1 in Q2 2016.
  • Brookmont Capital Management's portfolio value fell 12% quarter-over-quarter to $275M.

Based on Brookmont Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.